Preclinical safety of topically administered nanostructured lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies
- 1 October 2019
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 569, 118484
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund
- UPV/EHU
- MICINN
- ERDF (IT907-16)
This publication has 19 references indexed in Scilit:
- LL37 loaded nanostructured lipid carriers (NLC): A new strategy for the topical treatment of chronic woundsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2016
- Transition from inflammation to proliferation: a critical step during wound healingCellular and Molecular Life Sciences, 2016
- Development and in vitro evaluation of lipid nanoparticle-based dressings for topical treatment of chronic woundsInternational Journal of Pharmaceutics, 2015
- Biodistribution of nanostructured lipid carriers: A tomographic studyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- The topical administration of rhEGF-loaded nanostructured lipid carriers (rhEGF-NLC) improves healing in a porcine full-thickness excisional wound modelJournal of Controlled Release, 2015
- A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db/db miceJournal of Controlled Release, 2014
- Objective assessment of nanoparticle disposition in mammalian skin after topical exposureJournal of Controlled Release, 2012
- Wound Repair and RegenerationEuropean Surgical Research, 2012
- Potential Use of Nanostructured Lipid Carriers for Topical Delivery of FlurbiprofenJournal of Pharmaceutical Sciences, 2011
- Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal productsInternational Journal of Pharmaceutics, 2009